UNSPSC 51341801: Darunavir

This classification denotes a protease inhibitor with the molecular formula C27H37N3O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YO603Y8113, chemically known as n-((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1s,2r,5r)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide but generally known as darunavir, which bears US NIH Compound Identifier 213039. European Medicines Agency schedules Darunavir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25394.

UNSPSC 51341801 Darunavir is a Commodity code, but the recent state and local opportunities tagged under it show little alignment with the code's nominal pharmaceutical scope. The four solicitations on file span naloxone and drug deactivation systems procurement by a Florida county health authority, a Texas HHS information-gathering initiative on direct-to-manufacturer pharmacy programs, a Tampa Fire Department bid for medical and first aid supplies, and a multi-state cooperative purchasing agreement for generic pharmaceuticals and OTC products. The code appears to serve as a catch-all tag for pharmacy-related buys rather than a specific antiretroviral medication line. State and local governments use this code to solicit pharmaceutical products, medical supplies, and related services through county health departments, municipal fire rescue divisions, state health and human services commissions, and multi-jurisdictional cooperative purchasing vehicles such as the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP).

Recent activity spans Florida, Texas, Minnesota, and Oregon through MMCAP participation. Seminole County, Florida issued an IFB on June 30, 2026 for naloxone and drug deactivation systems with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to Sanford, Florida. The City of Tampa's Purchasing Department released an IFB (26-P-00145) on March 25, 2026 for medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a response deadline of March 13, 2026; this solicitation is sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission posted an RFI on April 3, 2026 exploring vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. MMCAP, administered by the Minnesota Department of Administration, issued an RFP due March 26, 2026 for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, effective July 1, 2026, with evaluation weighted 75 percent on price competitiveness. Vendors pursuing this code should verify the specific work scope in each RFP or RFQ, as the Darunavir code does not consistently map to the pharmaceutical products and services actually being procured.